Polpharma buys Bioton's antibiotics business
This article was originally published in Scrip
Executive Summary
Polpharma, one of Poland's largest pharmaceutical manufacturers, is buying an antibiotics production business from Bioton, another local company, for PLN 80 million ($8 million). Poland's office of competition and consumer protection has approved the deal.